INDOMETHACIN SUSTAINED-RELEASE

被引：4

作者：

GREEN, JA ^{[1
]}

机构：

[1] CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH 44106

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1984年 / 18卷 / 12期

关键词：

D O I：

10.1177/106002808401801222

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：1004 / 1007

页数：4

相关论文

共 28 条

[1] ALVAN G, 1975, CLIN PHARMACOL THER, V18, P364
[2] SERUM LEVEL MONITORING AND CLINICAL PHARMACOKINETICS OF LITHIUM
AMDISEN, A
[J]. CLINICAL PHARMACOKINETICS, 1977, 2 (02) : 73 - 92
[3] INDOMETHACIN IN RHEUMATOID-ARTHRITIS - CLINICAL EFFECTS, PHARMACOKINETICS, AND PLATELET STUDIES IN RESPONDERS AND NONRESPONDERS
BABER, N
HALLIDAY, LDC
VANDENHEUVEL, WJA
WALKER, RW
SIBEON, R
KEENAN, JP
LITTLER, T
ORME, MLE
[J]. ANNALS OF THE RHEUMATIC DISEASES, 1979, 38 (02) : 128 - 136
[4] BIOAVAILABILITY OF INDOMETHACIN FROM 2 MULTIPLE-UNITS CONTROLLED-RELEASE FORMULATIONS
BECHGAARD, H
BRODIE, RR
CHASSEAUD, LF
HOUMOLLER, P
HUNTER, JO
SIKLOS, P
TAYLOR, T
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (06) : 511 - 515
[5] THE USE OF CRITICAL FLICKER FUSION FREQUENCY TEST FOR EVALUATING SOME CENTRAL NERVOUS EFFECTS OF 2 INDOMETHACIN FORMULATIONS
CARLESS, JE
ROWE, JS
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (05) : 336 - 337
[6] DUGGAN DE, 1981, NZ MED J, V93, P261
[7] FASCHING U, 1978, WIEN MED WOCHENSCHR, V128, P1
[8] FLOWER RJ, 1980, PHARMACOL BASIS THER, P705
[9] EVALUATION OF SUSTAINED-RELEASE INDOMETHACIN IN OSTEOARTHRITIS
GENGOS, DC
NEU, DC
MIOLA, SR
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1982, 12 (02) : 142 - 146
[10] INDOCIN SR (INDOMETHACIN, MSD) IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID-ARTHRITIS
HART, CB
RHYMER, AR
MIOLA, SR
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1982, 12 (02) : 147 - 151